Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Linezolid
- Therapeutic area
- Anti-infectives
- Drug class
- Oxazolidinone antibacterials
- ATC
- J01
- Strength
- 2 mg/200 mL
- Dosage form
- IV infusion
- Pack
- 200ml
- Registration no.
- 070362
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Linexa (Linezolid) is used for
Linezolid is an antibiotic from a group called oxazolidinones. It works by stopping the bacteria that cause an infection from growing. It is a prescription-only medicine that comes as tablets or a liquid to swallow, and you will usually need regular blood tests while you take it.
- Pneumonia (a serious lung infection)
- Some serious skin and soft tissue infections
- Some chest and bone infections, often allowing treatment to continue at home with tablets instead of a hospital drip
- Drug-resistant tuberculosis (TB), as one part of combination treatments recommended by WHO
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction: swelling of the face or neck, wheezing, trouble breathing or swallowing, a widespread rash or a fast heartbeat.
- Get urgent help for any change in your eyesight, such as blurred vision, changes in how you see colours, or loss of side vision.
- Get urgent help for bleeding gums, black tarry stools, or unexpected bleeding or bruising.
- Get urgent help for fits (seizures) or a severe headache.
Side effects, warnings and interactions for Linezolid
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Linexa 2 mg/200 mL IV infusion
Linexa 2 mg/200 mL IV infusion contains Linezolid 2 mg/200 mL. It is registered with DRAP by Lucky Core Industries Limited (registration no. 070362). Its official price is PKR 738.63 for a pack of 200ml. This price has applied since 22 July 2026. Linexa is also available as 400 mg tablet and 600 mg tablet. No other brand of Linezolid 2 mg/200 mL in this form is listed in Pakistan.
Other strengths of Linexa
Other brands of Linezolid 2 mg/200 mL infusion in Pakistan
No other brand of Linezolid 2 mg/200 mL infusion is listed in Pakistan. See all strengths and forms of Linezolid →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Linexa, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Lucky Core Industries Limited, Karachi
- DRAP registration
- 070362
- Phone
- +92 21 111 100 200
- Website
- https://www.luckycore.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 24 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (200ml). Current price PKR 738.63, effective 22 Jul 2026.
Cite this price history
MedInfoBase. Linexa 2 mg/200 mL, 200ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/linexa-2-mg-200-ml-070362-200ml-lucky-core-industries-limited/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 738.63 | 2026-07-22 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 070362Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.